Suppr超能文献

急性早幼粒细胞白血病极早期死亡的预测因素:一项回顾性真实世界队列研究

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.

作者信息

Infante Joana, Esteves Graça, Raposo João, de Lacerda João Forjaz

机构信息

Serviço de Hematologia E Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Lisbon, Portugal.

Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

出版信息

Ann Hematol. 2023 Nov;102(11):3031-3037. doi: 10.1007/s00277-023-05422-z. Epub 2023 Aug 31.

Abstract

Early death (ED) is still the major obstacle to cure in acute promyelocytic leukemia (APL). Most studies focus on 30-day ED; however, little is known on predictors of death before starting APL treatment (very early death - VED) and on predictors of 7-day ED, the period with most deaths due to thrombohemorrhagic diathesis. We hypothesized whether the severity of the coagulopathy of APL could predict VED and 7-day ED. We also aimed to evaluate other characteristics associated with these outcomes. We undertook a retrospective, single-center observational study including newly diagnosed APL patients admitted to our institution between January 2000 and November 2022. Baseline demographical, clinical, and laboratorial data were collected. Statistical analysis was performed using Stata. One hundred four patients were included. The VED rate was 4.8%. A DIC Score ≥ 7 (p = 0.045), serum creatinine > 1.5 mg/dL (p < 0.001%), a DIC Score ≥ 6 within 24 h (p = 0.009), and mechanical ventilation (p < 0.001) were associated with VED. The 7-day ED rate was 12.5%. High-risk (p = 0.007) and hypogranular APL (p = 0.029), DIC Score at diagnosis (p = 0.047), DIC Score ≥ 7 (p = 0.043), DIC Score ≥ 6 within 24 h (p = 0.025), PT prolongation > 6 s (p = 0.002), and creatinine > 1.5 mg/dL (p = 0.004) were associated with 7-day ED. However, only elevated creatinine emerged as an independent predictor of 7-day ED (OR 21.4; p = 0.008). Our study shows that in patients with APL, an elevated creatinine at diagnosis strongly predicts for 7-day ED. A DIC Score ≥ 7 and a Score that remains ≥ 6 within 24 h and a serum creatinine > 1.5 mg/dL significantly associated with VED.

摘要

早期死亡(ED)仍是急性早幼粒细胞白血病(APL)治疗中的主要障碍。大多数研究聚焦于30天内的早期死亡;然而,对于APL治疗开始前的死亡预测因素(极早期死亡 - VED)以及7天内早期死亡的预测因素了解甚少,7天内是因血栓出血素质导致死亡最多的时期。我们推测APL凝血障碍的严重程度是否可预测VED和7天内早期死亡。我们还旨在评估与这些结局相关的其他特征。我们进行了一项回顾性、单中心观察性研究,纳入了2000年1月至2022年11月期间在我们机构收治的新诊断APL患者。收集了基线人口统计学、临床和实验室数据。使用Stata进行统计分析。共纳入104例患者。VED发生率为4.8%。弥散性血管内凝血(DIC)评分≥7(p = 0.04)、血清肌酐>1.5mg/dL(p < 0.001%)、24小时内DIC评分≥6(p = 0.00)和机械通气(p < 0.001)与VED相关。7天内早期死亡发生率为12.5%。高危(p = 0.007)和低颗粒型APL(p = 0.029)、诊断时的DIC评分(p = 0.047)、DIC评分≥7(p = 0.043)、24小时内DIC评分≥6(p = 0.025)、凝血酶原时间(PT)延长>6秒(p = 0.002)和肌酐>1.5mg/dL(p = 0.004)与7天内早期死亡相关。然而,只有肌酐升高是7天内早期死亡的独立预测因素(比值比21.4;p = 0.008)。我们的研究表明,在APL患者中,诊断时肌酐升高强烈预测7天内早期死亡。DIC评分≥7以及24小时内评分持续≥6和血清肌酐>1.5mg/dL与VED显著相关。

相似文献

1
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.
Ann Hematol. 2023 Nov;102(11):3031-3037. doi: 10.1007/s00277-023-05422-z. Epub 2023 Aug 31.
4
Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Korean J Intern Med. 2015 Nov;30(6):884-90. doi: 10.3904/kjim.2015.30.6.884. Epub 2015 Oct 30.
5
Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Front Immunol. 2023 Mar 31;14:1100151. doi: 10.3389/fimmu.2023.1100151. eCollection 2023.
8
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
Ann Hematol. 2022 May;101(5):1049-1057. doi: 10.1007/s00277-022-04798-8. Epub 2022 Feb 21.
10
Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Thromb Res. 2022 Feb;210:33-41. doi: 10.1016/j.thromres.2021.12.020. Epub 2021 Dec 29.

引用本文的文献

本文引用的文献

1
Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia.
J Oncol Pharm Pract. 2021 Oct;27(7):1779-1783. doi: 10.1177/1078155221990091. Epub 2021 Jan 26.
2
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all.
Leuk Lymphoma. 2019 Dec;60(13):3107-3115. doi: 10.1080/10428194.2019.1613540. Epub 2019 Dec 16.
3
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25.
4
Real-life Outcomes on Acute Promyelocytic Leukemia in Brazil - Early Deaths Are Still a Problem.
Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):e116-e122. doi: 10.1016/j.clml.2018.11.004. Epub 2018 Nov 12.
5
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.
Thromb J. 2018 Jul 11;16:14. doi: 10.1186/s12959-018-0168-2. eCollection 2018.
6
Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
Eur J Cancer. 2014 Apr;50(6):1159-68. doi: 10.1016/j.ejca.2013.11.023. Epub 2014 Jan 15.
7
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验